Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. Keeping that in mind, here is one stock likely to meet or exceed Wall Street’s lofty expectations and two where analysts may be overlooking some important risks.

Two Stocks to Sell:

UiPath (PATH)

Consensus Price Target: $13.50 (26.4% implied return)

Starting with robotic process automation (RPA) and evolving into a comprehensive automation powerhouse, UiPath (NYSE: PATH) provides an AI-powered business automation platform that enables organizations to create software robots that mimic human actions to streamline repetitive tasks and processes.

Why Does PATH Fall Short?

1. Revenue increased by 11% annually over the last two years, acceptable on an absolute basis but tepid for a software company enjoying secular tailwinds
2. Products, pricing, or go-to-market strategy may need some adjustments as its 7.4% average billings growth over the last year was weak
3. Estimated sales growth of 9.1% for the next 12 months implies demand will slow from its two-year trend

UiPath’s stock price of $10.68 implies a valuation ratio of 3.2x forward price-to-sales. To fully understand why you should be careful with PATH, check out our full research report (it’s free).

ICF International (ICFI)

Consensus Price Target: $105.25 (61.4% implied return)

Operating at the intersection of policy, technology, and implementation for over five decades, ICF International (NASDAQ: ICFI) provides professional consulting services and technology solutions to government agencies and commercial clients across energy, health, environment, and security sectors.

Why Are We Out on ICFI?

1. Products and services are facing significant end-market challenges during this cycle as sales have declined by 3.9% annually over the last two years
2. Backlog has dropped by 6.1% on average over the past two years, suggesting it’s losing orders as competition picks up
3. Earnings per share have dipped by 4% annually over the past two years, which is concerning because stock prices follow EPS over the long term

ICF International is trading at $65.22 per share, or 8.4x forward P/E. Read our free research report to see why you should think twice about including ICFI in your portfolio.

One Stock to Buy:

McKesson (MCK)

Consensus Price Target: $949.73 (23.3% implied return)

With roots dating back to 1833, making it one of America's oldest continuously operating businesses, McKesson (NYSE: MCK) is a healthcare services company that distributes pharmaceuticals, medical supplies, and provides technology solutions to pharmacies, hospitals, and healthcare providers.

Why Do We Love MCK?

1. Annual revenue growth of 14.3% over the last two years beat the sector average and underscores the unique value of its offerings
2. Enormous revenue base of $403.4 billion gives it economies of scale and advantages over new entrants due to the industry’s regulatory complexity
3. Share repurchases have amplified shareholder returns as its annual earnings per share growth of 17.9% exceeded its revenue gains over the last five years

At $770.00 per share, McKesson trades at 17.2x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.